Abbadessa G, Miele G, Maida E, Vanore E, et al. Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis. Mult Scler 2023 Jan 22:13524585221147635. doi: 10.1177/13524585221147635.
PMID: 36683286